| Name | Nicardipine hydrochloride |
| Description | Nicardipine hydrochloride (YC-93 Hydrochloride) is the hydrochloride salt form of nicardipine, a synthetic derivative of nitrophenyl-pyridine and potent calcium channel blocker, Nicardipine (Nifedipine Family) blocks calcium ions from certain cell walls and inhibits contraction of coronary and peripheral arteries, resulting in lowered oxygen requirements for heart muscle and decreased arterial contraction and spasm. It is used clinically as a cerebral and coronary vasodilator. |
| In vitro | Nicardipine significantly reduced systolic blood pressure in spontaneously hypertensive rats. In spontaneously hypertensive rats, Nicardipine significantly decreased the intima-media thickness and increased the lumen area at the level of cerebral arteries and small molluscum arteriosum.Nicardipine increased the number of neurons in the occipital cortex and frontal cortex in the SHR and inhibited the proliferation and hypertrophy of GFAP-positive astrocytes.Nicardipine also increased the number of neurons in the CA1 area of the hippocampus. increase in the number of neurons in the CA1 region of the hippocampus and reduced the size and number of astrocytes in gray and white matter. Nicardipine (5 mg/kg) in combination with flunarizine (80 mg/kg) and nimodipine (80 mg/kg) significantly potentiated the protective effect of ethosuximide (50 mg/kg) or valproic acid (100 mg/kg) against clonic seizures in mice. Nicardipine (40 mg/kg, 2 times/day for 8 weeks) reduced plaque area by 49.2% in rabbits (cholesterol-fed).Nicardipine (40 mg/kg) reduced aortic cholesterol accumulation in cholesterol-fed rabbits by 74.5%.Nicardipine (100 mg/kg) caused a significant transient reduction in cat Nicardipine (100 mg/kg) caused a significant transient reduction in retinal blood flow in cats. Although Nicardipine (100 mg/kg) decreased mean arterial blood pressure in cats, it significantly increased blood flow to the ONH, suggesting that Nicardipine benefits optic nerve hypoplasia tissue. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (3.88 mM), Sonication is recommended.
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 45 mg/mL (87.21 mM), Sonication is recommended.
|
| Keywords | YC93 Hydrochloride | YC-93 | YC93 | YC 93 Hydrochloride | YC 93 | RS69216 | RS 69216 | pressure | Nicardipine hydrochloride | Nicardipine | mAChR | Inhibitor | inhibit | cardiac | CalciumChannel | Calcium Channel | Ca2+ channels | Ca channels | blood | blocker | Autophagy | angina | AdrenergicReceptor | Adrenergic Receptor |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | 2,4,6-Tri-tert-butylphenol | Tamoxifen | Guanidine hydrochloride | Hydroxychloroquine | Paeonol | Naringin | N,N-Dicyclohexylcarbodiimide | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Neuroprotective Compound Library | Inhibitor Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
United States
